Phase I trial of CF 101.

Trial Profile

Phase I trial of CF 101.

Phase of Trial: Phase I

Latest Information Update: 10 May 2013

At a glance

  • Drugs Piclidenoson (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions
  • Most Recent Events

    • 10 May 2013 Status changed from not yet recruiting to completed, as reported in a Seikagaku Corporation media release.
    • 20 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top